- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Osimertinib – July 2018
Osimertinib: Tablet 40 mg, Tablet 80 mg; Tagrisso®
Last updated
9 November 2018